These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 35852946)

  • 1. Engineering a Nano/Biointerface for Cell and Organ-Selective Drug Delivery.
    Song D; Xu Q
    Langmuir; 2022 Aug; 38(30):9092-9098. PubMed ID: 35852946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein corona: challenges and opportunities for targeted delivery of nanomedicines.
    Jiang Z; Chu Y; Zhan C
    Expert Opin Drug Deliv; 2022 Jul; 19(7):833-846. PubMed ID: 35738018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nano-Bio Interactions in Cancer: From Therapeutics Delivery to Early Detection.
    Liu Y; Wang J; Xiong Q; Hornburg D; Tao W; Farokhzad OC
    Acc Chem Res; 2021 Jan; 54(2):291-301. PubMed ID: 33180454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Crown and the Scepter: Roles of the Protein Corona in Nanomedicine.
    Cai R; Chen C
    Adv Mater; 2019 Nov; 31(45):e1805740. PubMed ID: 30589115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The biomolecular corona of nanomedicines: effects on nanomedicine outcomes and emerging opportunities.
    Salvati A
    Curr Opin Biotechnol; 2024 Jun; 87():103101. PubMed ID: 38461749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Nano-Bio Interactions of Nanomedicines: Understanding the Biochemical Driving Forces and Redox Reactions.
    Wang Y; Cai R; Chen C
    Acc Chem Res; 2019 Jun; 52(6):1507-1518. PubMed ID: 31149804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanistic Understanding of Protein Corona Formation around Nanoparticles: Old Puzzles and New Insights.
    Nienhaus K; Nienhaus GU
    Small; 2023 Jul; 19(28):e2301663. PubMed ID: 37010040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of protein corona on the biological behavior of targeting nanomedicines.
    Farshbaf M; Valizadeh H; Panahi Y; Fatahi Y; Chen M; Zarebkohan A; Gao H
    Int J Pharm; 2022 Feb; 614():121458. PubMed ID: 35017025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Research progress and application opportunities of nanoparticle-protein corona complexes.
    Huang W; Xiao G; Zhang Y; Min W
    Biomed Pharmacother; 2021 Jul; 139():111541. PubMed ID: 33848776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An In Situ Investigation of the Protein Corona Formation Kinetics of Single Nanomedicine Carriers by Self-Regulated Electrochemiluminescence Microscopy.
    Xing Z; Gou X; Jiang LP; Zhu JJ; Ma C
    Angew Chem Int Ed Engl; 2023 Sep; 62(39):e202308950. PubMed ID: 37553293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanoparticle protein corona evolution: from biological impact to biomarker discovery.
    Kamaly N; Farokhzad OC; Corbo C
    Nanoscale; 2022 Feb; 14(5):1606-1620. PubMed ID: 35076049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perspectives on Protein-Nanoparticle Interactions at the
    He Z; Qu S; Shang L
    Langmuir; 2024 Apr; 40(15):7781-7790. PubMed ID: 38572817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The biomolecule corona mediates pulmonary delivery of nanomedicine.
    Subramaniam S; Joyce P; Prestidge CA
    Eur J Pharm Biopharm; 2024 Sep; 202():114420. PubMed ID: 39038525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In-vitro in-vivo correlation (IVIVC) in nanomedicine: Is protein corona the missing link?
    Jain P; Pawar RS; Pandey RS; Madan J; Pawar S; Lakshmi PK; Sudheesh MS
    Biotechnol Adv; 2017 Nov; 35(7):889-904. PubMed ID: 28844973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging well-tailored nanoparticulate delivery system based on in situ regulation of the protein corona.
    Li Z; Wang Y; Zhu J; Zhang Y; Zhang W; Zhou M; Luo C; Li Z; Cai B; Gui S; He Z; Sun J
    J Control Release; 2020 Apr; 320():1-18. PubMed ID: 31931050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanotechnology based drug delivery systems: Does shape really matter?
    Shah S; Famta P; Bagasariya D; Charankumar K; Amulya E; Kumar Khatri D; Singh Raghuvanshi R; Bala Singh S; Srivastava S
    Int J Pharm; 2022 Sep; 625():122101. PubMed ID: 35961415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanomedicine to overcome antimicrobial resistance: challenges and prospects.
    Zou W; McAdorey A; Yan H; Chen W
    Nanomedicine (Lond); 2023 Feb; 18(5):471-484. PubMed ID: 37170884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of surface chemistry and morphology of nanoparticles on protein corona formation.
    Bilardo R; Traldi F; Vdovchenko A; Resmini M
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2022 Jul; 14(4):e1788. PubMed ID: 35257495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance and implications of nanoparticle-biological corona fingerprints in diagnosis, prognosis, and therapeutics for diverse disorders.
    Ren J; Zhang S; Liu S
    Nanoscale; 2023 Jul; 15(27):11422-11433. PubMed ID: 37382526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanoparticle-protein corona complex: understanding multiple interactions between environmental factors, corona formation, and biological activity.
    Tomak A; Cesmeli S; Hanoglu BD; Winkler D; Oksel Karakus C
    Nanotoxicology; 2021 Dec; 15(10):1331-1357. PubMed ID: 35061957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.